Stay updated on Sitravatinib Combo in Clear-Cell RCC Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added a Locations section listing Texas as a site; removed the HHS Vulnerability Disclosure and the Texas Locations entry.
    Difference
    0.2%
    Check dated 2025-12-24T16:29:07.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The publication status text updated to indicate auto-fill from PubMed and the revision version updated to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:53:21.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Notice about government funding and operating status was removed from the page. This does not affect the study details, eligibility criteria, or how to participate.
    Difference
    0.4%
    Check dated 2025-11-18T07:33:55.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    No significant changes to the study record are evident; the page content and major sections appear unchanged.
    Difference
    0.5%
    Check dated 2025-10-27T21:09:05.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Updated the page to v3.2.0 and added a government-operating-status notice with links; removed the previous v3.1.0 reference.
    Difference
    5%
    Check dated 2025-10-06T08:23:32.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Term naming updated from 'Clear cell renal carcinoma' to 'Clear cell carcinoma of kidney' with a version bump to v3.1.0.
    Difference
    0.4%
    Check dated 2025-09-29T04:55:26.000Z thumbnail image

Stay in the know with updates to Sitravatinib Combo in Clear-Cell RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page.